BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38106407)

  • 21. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.
    Cho S; Mehra V; Thoma-Uszynski S; Stenger S; Serbina N; Mazzaccaro RJ; Flynn JL; Barnes PF; Southwood S; Celis E; Bloom BR; Modlin RL; Sette A
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12210-5. PubMed ID: 11035787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
    Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
    Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.
    Lewinsohn DA; Winata E; Swarbrick GM; Tanner KE; Cook MS; Null MD; Cansler ME; Sette A; Sidney J; Lewinsohn DM
    PLoS Pathog; 2007 Sep; 3(9):1240-9. PubMed ID: 17892322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
    Fayolle C; Bauche C; Ladant D; Leclerc C
    Vaccine; 2004 Dec; 23(5):604-14. PubMed ID: 15542180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.
    Dadaglio G; Moukrim Z; Lo-Man R; Sheshko V; Sebo P; Leclerc C
    Infect Immun; 2000 Jul; 68(7):3867-72. PubMed ID: 10858196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Mycobacterium tuberculosis CD8 T Cell Antigens/Epitopes Identified by a Proteomic Peptide Library.
    Lewinsohn DM; Swarbrick GM; Cansler ME; Null MD; Rajaraman V; Frieder MM; Sherman DR; McWeeney S; Lewinsohn DA
    PLoS One; 2013; 8(6):e67016. PubMed ID: 23805289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of HLA-E Binding
    Ruibal P; Franken KLMC; van Meijgaarden KE; van Wolfswinkel M; Derksen I; Scheeren FA; Janssen GMC; van Veelen PA; Sarfas C; White AD; Sharpe SA; Palmieri F; Petrone L; Goletti D; Abeel T; Ottenhoff THM; Joosten SA
    J Immunol; 2022 Oct; 209(8):1555-1565. PubMed ID: 36096642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.
    Caccamo N; Pietra G; Sullivan LC; Brooks AG; Prezzemolo T; La Manna MP; Di Liberto D; Joosten SA; van Meijgaarden KE; Di Carlo P; Titone L; Moretta L; Mingari MC; Ottenhoff TH; Dieli F
    Eur J Immunol; 2015 Apr; 45(4):1069-81. PubMed ID: 25631937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
    Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
    Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector.
    Connell TG; Shey MS; Seldon R; Rangaka MX; van Cutsem G; Simsova M; Marcekova Z; Sebo P; Curtis N; Diwakar L; Meintjes GA; Leclerc C; Wilkinson RJ; Wilkinson KA
    Clin Vaccine Immunol; 2007 Jul; 14(7):847-54. PubMed ID: 17522328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells.
    Svedova M; Masin J; Fiser R; Cerny O; Tomala J; Freudenberg M; Tuckova L; Kovar M; Dadaglio G; Adkins I; Sebo P
    Immunol Cell Biol; 2016 Apr; 94(4):322-33. PubMed ID: 26437769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8
    Harriff MJ; Wolfe LM; Swarbrick G; Null M; Cansler ME; Canfield ET; Vogt T; Toren KG; Li W; Jackson M; Lewinsohn DA; Dobos KM; Lewinsohn DM
    Sci Rep; 2017 Jul; 7(1):4622. PubMed ID: 28676677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis.
    Duan Z; Li D; Jia Q; Xu J; Chen X; Xu Z; Liu H; Chen B; Wen J
    Microbiol Immunol; 2015 Dec; 59(12):705-15. PubMed ID: 26577013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-E-restricted CD8
    La Manna MP; Orlando V; Prezzemolo T; Di Carlo P; Cascio A; Delogu G; Poli G; Sullivan LC; Brooks AG; Dieli F; Caccamo N
    Am J Respir Cell Mol Biol; 2020 Apr; 62(4):430-439. PubMed ID: 31697586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.